%0 Journal Article
%T Which chronic diseases and disease combinations are specific to multimorbidity in the elderly? Results of a claims data based cross-sectional study in Germany
%A Hendrik van den Bussche
%A Daniela Koller
%A Tina Kolonko
%A Heike Hansen
%A Karl Wegscheider
%A Gerd Glaeske
%A Eike-Christin von Leitner
%A Ingmar Sch£¿fer
%A Gerhard Sch£¿n
%J BMC Public Health
%D 2011
%I BioMed Central
%R 10.1186/1471-2458-11-101
%X The study is based on the claims data of all insured policy holders aged 65 and older (n = 123,224). Adjustment for age and gender was performed for the German population in 2004. A person was defined as multimorbid if she/he had at least 3 diagnoses out of a list of 46 chronic conditions in three or more quarters within the one-year observation period. Prevalences and risk-ratios were calculated for the multimorbid and non-multimorbid samples in order to identify diagnoses more specific to multimorbidity and to detect excess prevalences of multimorbidity patterns.62% of the sample was multimorbid. Women in general and patients receiving statutory nursing care due to disability are overrepresented in the multimorbid sample. Out of the possible 15,180 combinations of three chronic conditions, 15,024 (99%) were found in the database. Regardless of this wide variety of combinations, the most prevalent individual chronic conditions do also dominate the combinations: Triads of the six most prevalent individual chronic conditions (hypertension, lipid metabolism disorders, chronic low back pain, diabetes mellitus, osteoarthritis and chronic ischemic heart disease) span the disease spectrum of 42% of the multimorbid sample. Gender differences were minor. Observed-to-expected ratios were highest when purine/pyrimidine metabolism disorders/gout and osteoarthritis were part of the multimorbidity patterns.The above list of dominating chronic conditions and their combinations could present a pragmatic start for the development of needed guidelines related to multimorbidity.Driven by increasing longevity and the rise of healthcare costs, a growing interest in multimorbidity is observable in industrialized countries [1]. Still, there is a far smaller number of studies on multimorbidity than on individual chronic diseases [2]. Pioneering work on multimorbidity has been done in a few countries, in particular Australia [3,4], Canada [5,6], The Netherlands [7,8], and Sweden [9,10]. Al
%U http://www.biomedcentral.com/1471-2458/11/101